Menu
Back to User profile » Dr Cristoforo Incorvaia
Papers published by Dr Cristoforo Incorvaia:
Patient-reported outcomes and considerations in the management of COPD: focus on indacaterol/glycopyrronium bromide
Ridolo E, Pellicelli I, Gritti B, Incorvaia C
Patient Preference and Adherence 2019, 13:145-150
Published Date: 14 January 2019
Two decades with omalizumab: what we still have to learn
Incorvaia C, Mauro M, Makri E, Leo G, Ridolo E
Biologics: Targets and Therapy 2018, 12:135-142
Published Date: 26 October 2018
Diagnosis of exercise-induced anaphylaxis: current insights [Corrigendum]
Pravettoni V, Incorvaia C
Journal of Asthma and Allergy 2016, 9:207-208
Published Date: 22 November 2016
Diagnosis of exercise-induced anaphylaxis: current insights
Pravettoni V, Incorvaia C
Journal of Asthma and Allergy 2016, 9:191-198
Published Date: 27 October 2016
In children allergic to ragweed pollen, nasal inflammation is not influenced by monosensitization or polysensitization
Gelardi M, Bosoni M, Morelli M, Beretta S, Incorvaia C, Buttafava S, Landi M, Masieri S, Frati F, Quaranta N, Zuccotti GV
Journal of Inflammation Research 2016, 9:21-25
Published Date: 5 April 2016
Striving for optimal bronchodilation: focus on olodaterol
Incorvaia C, Montagni M, Makri E, Riario-Sforza GG, Ridolo E
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:439-444
Published Date: 1 March 2016
New combinations in the treatment of COPD: rationale for aclidinium–formoterol
Incorvaia C, Montagni M, Makri E, Ridolo E
Therapeutics and Clinical Risk Management 2016, 12:209-215
Published Date: 15 February 2016
New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis [Corrigendum]
Frati F, Cecchi L, Scala E, Ridolo E, Dell'Albani I, Makrì E, Pajno GB, Incorvaia C
Biologics: Targets and Therapy 2015, 9:45-46
Published Date: 29 June 2015
New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis
Frati F, Cecchi L, Scala E, Ridolo E, Dell'Albani I, Makrì E, Pajno G, Incorvaia C
Biologics: Targets and Therapy 2014, 8:221-226
Published Date: 12 September 2014
Seasonal changes in nasal cytology in mite-allergic patients
Gelardi M, Peroni DG, Incorvaia C, Quaranta N, De Luca C, Barberi S, Dell'Albani I, Landi M, Frati F, de Beaumont O
Journal of Inflammation Research 2014, 7:39-44
Published Date: 28 March 2014
Omalizumab, an anti-immunoglobulin E antibody: state of the art
Incorvaia C, Mauro M, Russello M, Formigoni C, Riario-Sforza GG, Ridolo E
Drug Design, Development and Therapy 2014, 8:197-207
Published Date: 7 February 2014
5-grass pollen tablets achieve disease control in patients with seasonal allergic rhinitis unresponsive to drugs: a real-life study
Pastorello EA, Losappio L, Milani S, Manzotti G, Fanelli V, Pravettoni V, Agostinis F, D'Arcais AF, Dell'Albani I, Puccinelli P, Incorvaia C, Frati F
Journal of Asthma and Allergy 2013, 6:127-133
Published Date: 4 December 2013
Role of indacaterol and the newer very long-acting β2-agonists in patients with stable COPD: a review
Ridolo E, Montagni M, Olivieri E, Riario-Sforza GG, Incorvaia C
International Journal of Chronic Obstructive Pulmonary Disease 2013, 8:425-432
Published Date: 18 September 2013
Shrinking the room for invasive ventilation in hypercapnic respiratory failure
Scarpazza P, Incorvaia C, Melacini C, Cattaneo R, Bonacina C, Riario-Sforza GG, Casali W
International Journal of Chronic Obstructive Pulmonary Disease 2013, 8:135-137
Published Date: 15 March 2013
Requirements for acquiring a high-quality house dust mite extract for allergen immunotherapy
Frati F, Incorvaia C, David M, Scurati S, Seta S, Padua G, Cattaneo E, Cavaliere C, Di Rienzo A, Dell'Albani I, Puccinelli P
Drug Design, Development and Therapy 2012, 6:117-123
Published Date: 18 May 2012
Seroprevalence of IgG anti-Toxocara species antibodies in a population of patients with suspected allergy
Qualizza R, Incorvaia C, Grande R, Makri E, Allegra L
International Journal of General Medicine 2011, 4:783-787
Published Date: 22 November 2011
Long-term survival in elderly patients with a do-not-intubate order treated with noninvasive mechanical ventilation
Scarpazza P, Incorvaia C, Amboni P, di Franco G, Raschi S, Usai P, Bernareggi M, Bonacina C, Melacini C, Cattaneo R, Bencini S, Pravettoni C, Riario-Sforza GG, Passalacqua G, Casali W
International Journal of Chronic Obstructive Pulmonary Disease 2011, 6:253-257
Published Date: 26 April 2011
The current role of sublingual immunotherapy in the treatment of allergic rhinitis in adults and children
Cristoforo Incorvaia, Simonetta Masieri, Silvia Scurati, et al
Journal of Asthma and Allergy 2011, 4:13-17
Published Date: 20 February 2011
Development of a sublingual allergy vaccine for grass pollinosis
Franco Frati, Silvia Scurati, Paola Puccinelli, et al
Drug Design, Development and Therapy 2010, 4:99-105
Published Date: 17 June 2010
Adherence issues related to sublingual immunotherapy as perceived by allergists
Silvia Scurati, Franco Frati, Gianni Passalacqua, et al
Patient Preference and Adherence 2010, 4:141-145
Published Date: 15 June 2010
Effects of pulmonary rehabilitation on exercise capacity in patients with COPD: A number needed to treat study
Gian Galeazzo Riario-Sforza, Cristoforo Incorvaia, Fulvia Paterniti, et al
International Journal of Chronic Obstructive Pulmonary Disease 2009, 4:315-319
Published Date: 21 August 2009